Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Changing Diabetes® World Tour

NCT01437072

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations
  • Novo Nordisk Investigational Site Paço de Arcos, Portugal
  • Novo Nordisk Investigational Site Riyadh, Saudi Arabia
  • Novo Nordisk Investigational Site Dubai, United Arab Emirates
View Trial Details
Completed

Evaluating the Use of Two Different Needles in Subjects With Diabetes

NCT00569426

Conditions
Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations
  • Novo Nordisk Investigational Site Cambridge, United Kingdom
  • Novo Nordisk Investigational Site Cardiff, United Kingdom
  • Novo Nordisk Investigational Site Church Village, United Kingdom
  • Novo Nordisk Investigational Site Dundee, United Kingdom
View Trial Details
Completed

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

NCT01068652

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Ain Témouchent, Algeria
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Constantine, Algeria
  • Novo Nordisk Investigational Site Oran, Algeria
View all 19 locations
View Trial Details
Completed

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

NCT01950637

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Princeton, New Jersey, United States
  • Novo Nordisk Investigational Site Mississauga, Canada
  • Novo Nordisk Investigational Site Copenhagen S, Denmark
  • Novo Nordisk Investigational Site Mainz, Germany
View Trial Details
Completed

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

NCT00976391

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Gilbert, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 209 locations
View Trial Details
Completed

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT00097877

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Tuscaloosa, Alabama, United States
  • Novo Nordisk Investigational Site Vestavia Hills, Alabama, United States
  • Novo Nordisk Investigational Site Searcy, Arkansas, United States
View all 73 locations
View Trial Details
Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

NCT00605111

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Blacktown, New South Wales, Australia
  • Novo Nordisk Investigational Site Broadmeadow, New South Wales, Australia
  • Novo Nordisk Investigational Site Fitzroy, Australia
  • Novo Nordisk Investigational Site Garran, Australia
View all 17 locations
View Trial Details

Related conditions